Sanal Fernandes

1PUBLICATIONS
5CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jun 06, 2025
Efficacy and Tolerability of a Low-Dose Continuous Regimen of Regorafenib in Refractory Synovial Sarcomas: A Single-Arm, Phase II Trial From India.

Sanal Fernandes, Sameer Rastogi, Kanu Priya Bhatia

Pageof 1

Frequent Collaborators

1 joint publications

Sameer Rastogi

1 joint publications

Kanu Priya Bhatia

1 joint publications

Shamim A Shamim

1 joint publications

Rambha Pandey